CRP and neoplasm: For instance, the CRP arrest cell-cycle at the sub G1 phase by negatively regulating the PI3K/AKT/mTOR signaling pathway in myeloid leukemia (25) and tongue squamous cell carcinoma (26) thus promoting tumor progression.